Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $311.47 | 12 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Astellas Pharma US Inc | $118.35 | 5 | $0 (2018) |
| Gilead Sciences, Inc. | $98.90 | 1 | $0 (2018) |
| Pharmacyclics LLC, an AbbVie Company | $67.36 | 4 | $0 (2022) |
| ABBVIE INC. | $16.31 | 1 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $10.55 | 1 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $16.31 | 1 | ABBVIE INC. ($16.31) |
| 2022 | $54.85 | 3 | Pharmacyclics LLC, an AbbVie Company ($54.85) |
| 2018 | $148.13 | 4 | Gilead Sciences, Inc. ($98.90) |
| 2017 | $92.18 | 4 | Astellas Pharma US Inc ($79.67) |
All Payment Transactions
12 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 08/29/2024 | ABBVIE INC. | EPKINLY (Drug), IMBRUVICA | Food and Beverage | In-kind items and services | $16.31 | General |
| Category: ONCOLOGY | ||||||
| 09/02/2022 | Pharmacyclics LLC, an AbbVie Company | IMBRUVICA (Drug) | Food and Beverage | In-kind items and services | $15.55 | General |
| Category: ONCOLOGY | ||||||
| 02/03/2022 | Pharmacyclics LLC, an AbbVie Company | IMBRUVICA (Drug) | Food and Beverage | In-kind items and services | $23.90 | General |
| Category: ONCOLOGY | ||||||
| 01/13/2022 | Pharmacyclics LLC, an AbbVie Company | IMBRUVICA (Drug) | Food and Beverage | In-kind items and services | $15.40 | General |
| Category: ONCOLOGY | ||||||
| 06/29/2018 | Astellas Pharma US Inc | XTANDI (Drug) | Food and Beverage | In-kind items and services | $15.53 | General |
| Category: ONCOLOGY | ||||||
| 05/10/2018 | Gilead Sciences, Inc. | Zydelig (Drug) | Food and Beverage | In-kind items and services | $98.90 | General |
| Category: ONC | ||||||
| 04/20/2018 | Novartis Pharmaceuticals Corporation | MEKINIST (Drug), TAFINLAR | Food and Beverage | In-kind items and services | $10.55 | General |
| Category: ONCOLOGY | ||||||
| 04/13/2018 | Astellas Pharma US Inc | XTANDI (Drug) | Food and Beverage | In-kind items and services | $23.15 | General |
| Category: ONCOLOGY | ||||||
| 10/20/2017 | Astellas Pharma US Inc | Xtandi (Drug) | Food and Beverage | In-kind items and services | $24.40 | General |
| Category: Oncology | ||||||
| 07/21/2017 | Astellas Pharma US Inc | Xtandi (Drug) | Food and Beverage | In-kind items and services | $32.27 | General |
| Category: Oncology | ||||||
| 06/02/2017 | Pharmacyclics LLC, An AbbVie Company | Imbruvica (Drug) | Food and Beverage | In-kind items and services | $12.51 | General |
| Category: Oncology | ||||||
| 05/19/2017 | Astellas Pharma US Inc | Xtandi (Drug) | Food and Beverage | In-kind items and services | $23.00 | General |
| Category: Oncology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2020 | 2 | 77 | 92 | $11,628 | $2,964 |
All Medicare Procedures & Services
2 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Facility | 2020 | 57 | 66 | $7,260 | $1,833 | 25.2% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Facility | 2020 | 20 | 26 | $4,368 | $1,131 | 25.9% |
About Dr. William Scott, M.D
Dr. William Scott, M.D is a Hematology & Oncology healthcare provider based in Reed City, Michigan. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/10/2005. The National Provider Identifier (NPI) number assigned to this provider is 1295736387.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. William Scott, M.D has received a total of $311.47 in payments from pharmaceutical and medical device companies, with $16.31 received in 2024. These payments were reported across 12 transactions from 5 companies. The most common payment nature is "Food and Beverage" ($311.47).
As a Medicare-enrolled provider, Scott has provided services to 77 Medicare beneficiaries, totaling 92 services with total Medicare billing of $2,964. Data is available for 1 year (2020–2020), covering 2 distinct procedure/service records.
Practice Information
- Specialty Hematology & Oncology
- Location Reed City, MI
- Active Since 08/10/2005
- Last Updated 12/09/2020
- Taxonomy Code 207RH0003X
- Entity Type Individual
- NPI Number 1295736387
Products in Payments
- Zydelig (Drug) $98.90
- Xtandi (Drug) $79.67
- IMBRUVICA (Drug) $54.85
- XTANDI (Drug) $38.68
- EPKINLY (Drug) $16.31
- Imbruvica (Drug) $12.51
- MEKINIST (Drug) $10.55
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.